Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Durability of Supplementary Rod Constructs-SuppleMentAry Rod Technique (SMART)-for Long-segment Posterior Instrumented Spinal Fusion Procedures: A Multicenter Retrospective Comparative Study With Dual-rod Constructs
- Spinal Fusion
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- AO Foundation, AO Spine
- Enrolment target
- 1,244
- Started
- 24 March 2025
- Main results due (estimated)
- 15 December 2027
- Study ends (estimated)
- 31 July 2029
- Observational model
- Cohort
- Time perspective
- Retrospective
- Sites
- 17 · 1 in India
- First posted
- 16 April 2024
- Registry updated
- 1 October 2026
Can you take part?
- Aged 45 years and over.
- Open to any sex.
- You need the condition being studied. Healthy volunteers are not accepted.
- Who they are looking for: Patients who underwent long-segment posterior thoracolumbar (TL) instrumented fusion
Age groups: adult, older adult. Sampling: non probability sample.
These are the headline rules. Every study has a longer list, and whether you are eligible is decided by the research team at the site, never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Age 45 years and older. * Patients receiving long-segment posterior TL instrumented fusion using either supplementary rod constructs or dual-rod constructs (the index surgery). * Long-segment is defined as the UIV at a thoracic level and the LIV at the sacrum/ilium. * Supplementary rod constructs are defined as: in addition to the traditional two primary rods, at least one supplementary rod (eg, accessory rods or satellite rods) is used, and at least one supplementary rod and one primary rod (ie, at least two rods) together must span multiple (≥ 2) vertebral levels. The supplementary rod constructs do not include rods connected end-to-end or side-to-side that do not bridge multiple vertebral levels. * The index surgery can be a primary surgery or a revision surgery. * The index surgery, staged or non-staged, must use posterior spinal fusion but can be in combination with other approaches such as an anterior procedure. * If the index surgery is a revision surgery, the primary rods must be replaced in the revision surgery, with the exception of Harrington or Luque rods which can remain in place. o If the Harrington or Luque rods remain in situ, they must already have the UIV at the thoracic level and the LIV at the sacrum/ilium, or an extension of the existing Harrington or Luque is performed such that the UIV is at the thoracic level and the LIV at the sacrum/ilium. * The index surgery was performed between January 1, 2014, and December 31, 2020, inclusive. * Minimum 3 months of FU after the index surgery. * Ability to provide informed consent according to the IRB/EC defined and approved procedures if applicable for retrospective data analysis. Exclusion Criteria: * Spinal fusion performed for acute trauma (ie, ≤ 1 year of trauma). * Spinal fusion performed for tumor. * Spinal fusion performed for infection. * Patients with Parkinson's Disease. * Patients with neuromuscular disorders. * Patients with spine malignancies requiring chemo- or radiation therapy.
What this study is about
In the sponsor’s own words, from the registry.
This is a multicenter retrospective comparative cohort study. The index surgery for this study is primary or revision long-segment posterior thoracolumbar (TL) instrumented fusion using either a supplementary rod construct or a dual-rod construct. Eligible patients who already had index surgery, will be identified for enrollment through a review of medical records of the participating surgeons at the study sites.
Read the detailed description
This multicenter retrospective comparative cohort study will enroll 1244 patients, who underwent primary or revision long-segment posterior thoracolumbar (TL) instrumented fusion using either a supplementary rod construct or a dual-rod construct. By comparing two groups of patients, ie, patients treated with supplementary rod constructs vs dual-rod constructs, in the setting of long-segment posterior instrumented spinal fusion, this study aims to provide quality evidence regarding the benefits of supplementary rod constructs in reducing the risk of RFs and other mechanical complications. This study shall provide the first long-term clinical evidence on clinical outcome and benefit of supplementary rod constructs.
All participating surgeons will be asked to identify a time point, denoted as X, when they started using predominantly either supplementary rod constructs or dual-rod constructs for long-segment posterior TL instrumented spinal fusion. This time point X must be on or before December 31, 2020 (the last eligible date for the index surgery). Participating surgeons will be instructed to select the time point X to be as early within the collection window as feasible to maximize the available FU period.
Once the time point X is identified for a participating surgeon, medical records of patients treated by this surgeon will be reviewed to identify consecutive eligible patients with the index surgery done between the time point X and December 31, 2020, inclusive. In the case that an eligible patient had undergone several surgeries during this period, the first primary or revision of long-segment posterior TL instrumented fusion using either a supplementary rod construct or a dual-rod construct is defined as the index surgery.
Patients will then be grouped based on the rod constructs into either the supplementary rod construct group or dual-rod construct group.
The study has two FU periods:
* The first FU period is the first 2 years after the index surgery. The primary analysis will be done using data from the first 2 years of FU. * The second FU period ends on December March 31, 20232024. The duration of this FU therefore ranges from 3 years and 3 months to 10 years and 3 months.
The primary study endpoint is the occurrence of the first RF within 2 years after the index surgery.
What participants receive
primary/revision long-segment posterior TL instrumented fusion with dual-rod constructs
The index surgery for this study is the primary or revision of long-segment posterior TL instrumented fusion using dual-rod construct.
Procedure: long-segment posterior TL instrumented fusion
primary/revision long-segment posterior TL instrumented fusion with supplementary rod constructs
The index surgery for this study is the primary or revision of long-segment posterior TL instrumented fusion using either a supplementary rod construct.
Procedure: long-segment posterior TL instrumented fusion
Interventions
long-segment posterior TL instrumented fusionProcedure
long-segment posterior TL instrumented fusion with either supplementary rod constructs or dual-rod constructs.
What the study measures
Primary outcomes
Rod fracture (RF)
Incidence of rod fracture(s)
Time frame: 2 years
Secondary outcomes
Time to rod fracture
Time to the first rod fracture after index surgery
Time frame: 2 years
Time to rod fracture
Time to the first rod fracture after index surgery
Time frame: 10 years and 3 months
Configurations of supplementary rod constructs
Descriptions of configurations of supplementary rod constructs
Time frame: Baseline
Treatment for rod fracture
Descriptions of different treatment strategies for rod fractures
Time frame: 10 years and 3 months
Recurrent RFs
Incidence of recurrent rod fractures
Time frame: 10 years and 3 months
Other mechanical failures
Other mechanical failures other than rod fractures
Time frame: 10 years and 3 months
Surgical complications
Selective surgical complications
Time frame: 10 years and 3 months
Who is running it
- Lead sponsor
- AO Foundation, AO Spine
- Sponsor type
- Other
- Responsible party
- The sponsor
- Organisation
- AO Foundation, AO Spine
- Data monitoring committee
- No
- US FDA-regulated drug
- No
- US FDA-regulated device
- No
- Sponsor's study ID
- SMART
Justin S Smith, MD, PhD
Principal investigator
Professor of Neurosurgery Chief of Spine Division, Fellowship Director University of Virginia
Study sites(17)
Kothari Medical Centre
Kolkata, India
Recruiting
- Saumayajit Basu, MDsaumyajitbasu@hotmail.com
Stanford Spine Clinic
Redwood City, California, United States
Recruiting
- Serena Hu, MDshu3@stanford.edu
University of California
Sacramento, California, United States
Recruiting
- Yashar Javidanyjavidan@ucdavis.edu
John Hopkis Hospital
Baltimore, Maryland, United States
Recruiting
University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Recruiting
- David Polly, MDpollydw@umn.edu
Washington University in St. Louis, School of Medicine
St Louis, Missouri, United States
Recruiting
Columbia University / NYP Och Spine Hospital
New York, New York, United States
Recruiting
University of Virginia
Charlottesville, Virginia, United States
Recruiting
- Justin S Smith, MD, PhD434-243-6339jss7f@virginia.edu
- Judith G BeenhakkerJGB3P@uvahealth.org
University of Calgary Spine
Calgary, Canada
Recruiting
University of Toronto
Toronto, Canada
Recruiting
University of Tokyo
Tokyo, Japan
Recruiting
Hospital Vall d´Hebron
Barcelona, Spain
Recruiting
- Ferran Pellisé, MD24361fpu@comb.es
Acibadem Maslak Hospital
Istanbul, Turkey (Türkiye)
Recruiting
- Caglar Yilgor, MDcaglaryilgor@gmail.com
- Ahmet Alanayaalanay@gmail.com
UCSF Spine Center
San Francisco, California, United States
Terminated
Washington University in St. Louis, School of Medicine, Saint Louis, Missouri 63110
St Louis, Missouri, United States
Completed
Duchess of Kent Children's Hospital
Hong Kong, China
Completed
Hamamatsu University School of Medicine
Hamamatsu, Japan
Completed
Showing 17 of 17 sites. 13 of 17 on this study are recruiting right now, and 1 is in India. A site can stop enrolling while the study as a whole is still open.
References and data sharing
- Participant data shared
- Undecided
Source: ClinicalTrials.gov record NCT06368245, status verified September 2026. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Interested in this study?
Tell us how to reach you and we will connect you with the study team. Or refer someone you care for, with their permission.
